Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Viridian Therapeutics, Inc. (VRDN) had Free Cash Flow of $-252.89M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$70.57M |
|
$-34.60M |
|
-- |
|
$70.57M |
|
$110.58M |
|
$-40.01M |
|
$5.41M |
|
$-34.60M |
|
$-34.60M |
|
$-34.60M |
|
$-34.60M |
|
$-34.60M |
|
$-34.60M |
|
$-40.01M |
|
$-41.04M |
|
81.78M |
|
81.78M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$571.91M |
|
$1.12M |
|
$5.22M |
|
$577.14M |
|
$50.70M |
|
$20.89M |
|
$23.47M |
|
$74.17M |
|
$314.09M |
|
$502.97M |
|
$502.97M |
|
82.23M |
|
| Cash Flow Statement Financials | |
$-252.64M |
|
$301.86M |
|
$20.83M |
|
$99.59M |
|
$169.65M |
|
$70.05M |
|
$32.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.28 |
|
-- |
|
-- |
|
0.04 |
|
0.04 |
|
100.00% |
|
-56.70% |
|
-56.70% |
|
-- |
|
-49.03% |
|
-49.03% |
|
|
Free Cash Flow |
$-252.89M |
-- |
|
-- |
|
-- |
|
0.12 |
|
-- |
|
-- |
|
-- |
|
-11.02% |
|
-6.88% |
|
-5.99% |
|
-6.60% |
|
$6.12 |
|
$-3.09 |
|
$-3.09 |
|